MétaCan
Menu
← Back to cohort
Record W4391162944 · doi:10.1093/ecco-jcc/jjad212.0193

P063 Interleukin-8 mucosal transcript as predictor of response to Vedolizumab treatment in Ulcerative Colitis: preliminary results from a prospective study

2024· article· en· W4391162944 on OpenAlexaboutno aff
A. Bota, Ahmed Musa, M C Dinu, Adrian Săftoiu, Mohamed Bashir Musa, S. Coman, Maria Dobre, Elena Milanesi, Cristian Tieranu

Bibliographic record

VenueJournal of Crohn s and Colitis · 2024
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsVedolizumabMedicineUlcerative colitisInternal medicineInflammatory bowel diseaseGastroenterologyColonoscopyColitisClinical trialDiseaseColorectal cancerCancer

Abstract

fetched live from OpenAlex

Abstract Background Vedolizumab (VDZ) is a safe, well tolerated and efficient biologic agent used for the treatment of inflammatory bowel disease (IBD), as confirmed by phase 3 randomised controlled trials. However, primary non-response and secondary loss-of-response to VDZ represent a clinically significant problem. The objectives of the present study are to assess the differences in mucosal gene expression profiles of patients with Ulcerative Colitis (UC) prior to VDZ initiation and to identify transcriptomic biomarkers capable of discriminating responders and non-responders to VDZ treatment. Methods Mucosal samples were collected during colonoscopy from patients with UC prior to VDZ initiation. The minimum extension of disease for study inclusion was left-sided colitis (E2 Montreal), and patients had at least moderate flare of clinical activity based on the total Mayo Score. Patients were dichotomized based on clinical response at week 10 in responders and non-responders. Clinical response at week 10 was defined as a decrease with >50 percent for both rectal bleeding score and stool frequency score according to the latest STRIDE-II recommendations for short-term targets. A commercially available panel of primers for 84 genes associated with IBD were assessed on mucosal samples through quantitative PCR. Results Eight patients with previous failure to anti-TNF agents, were sampled prior to VDZ initiation. We identified 3 responders and 5 primary non-responders at week 10 after VDZ treatment initiation. We found 15 genes up-regulated in non-responders compared to responders with a trend towards statistical significance (p=0.057). The highest fold-change was obtained for CXCL8. Conclusion We identified 15 mucosal transcripts differentially expressed in VDZ primary non-responder UC patients. Of those, the highest fold change was observed for CXCL8. Enlarging the cohort might contribute to achievement of statistical significance for the data presented. CXCL8 up-regulation seems to predict lack of response to VDZ treatment and represents an interesting future therapeutic target in UC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.264
Teacher spread0.256 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→